FDA Inspection 1319478 — Morepen Laboratories Limited

Morepen Laboratories Limited — FEI 3002807612

The FDA completed an inspection of Morepen Laboratories Limited on Apr 17, 2026 in Solan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Solan (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.